Maybe more is better

被引：8

作者：

Thigpen, T ^{[1
]}

机构：

[1] Univ Mississippi, Med Ctr, Div Oncol, Jackson, MS 39216 USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2003年 / 21卷 / 13期

关键词：

D O I：

10.1200/JCO.2003.93.115

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：2454 / 2456

页数：3

共 18 条

[1]

[Anonymous], P AM SOC CLIN ONCOLO

[2]

Browder T, 2000, CANCER RES, V60, P1878

[3]

COLOMBO N, 1993, P AN M AM SOC CLIN, V12, P255

[4] High-dose versus low-dose cisplatin in combination with cyclophosphamide and epidoxorubicin in suboptimal ovarian cancer: A randomized study of the gruppo oncologico nord-ovest [J].

Conte, PF ;

Bruzzone, M ;

Carnino, F ;

Gadducci, A ;

Algeri, R ;

Bellini, A ;

Boccardo, F ;

Brunetti, I ;

Catsafados, E ;

Chiara, S ;

Foglia, G ;

Gallo, I ;

Iskra, L ;

Mammoliti, S ;

Parodi, G ;

Ragni, N ;

Rosso, R ;

Rugiati, S ;

Rubagotti, A .

JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (02) :351-356

[5]

GORE ME, 1996, P AN M AM SOC CLIN, V15, P284

[6] IMPORTANCE OF MULTIAGENT CHEMOTHERAPY REGIMENS IN OVARIAN-CARCINOMA - DOSE INTENSITY ANALYSIS [J].

LEVIN, L ;

SIMON, R ;

HRYNIUK, W .

JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1993, 85 (21) :1732-1742

[7] DOSE INTENSITY ANALYSIS OF CHEMOTHERAPY REGIMENS IN OVARIAN-CARCINOMA [J].

LEVIN, L ;

HRYNIUK, WM .

JOURNAL OF CLINICAL ONCOLOGY, 1987, 5 (05) :756-767

[8] Phase III trial of standard-dose intravenous cisplatin plus paclitaxel versus moderately high-dose carboplatin followed by intravenous paclitaxel and intraperitoneal cisplatin in small-volume stage III ovarian carcinoma: An intergroup study of the Gynecologic Oncology Group, Southwestern Oncology Group, and Eastern Cooperative Oncology Group [J].

Markman, M ;

Bundy, BN ;

Alberts, DS ;

Fowler, JM ;

Clark-Pearson, DL ;

Carson, LF ;

Wadler, S ;

Sickel, J .

JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (04) :1001-1007

[9] RESPONSES TO 2ND-LINE CISPLATIN-BASED INTRAPERITONEAL THERAPY IN OVARIAN-CANCER - INFLUENCE OF A PRIOR RESPONSE TO INTRAVENOUS CISPLATIN [J].

MARKMAN, M ;

REICHMAN, B ;

HAKES, T ;

JONES, W ;

LEWIS, JL ;

RUBIN, S ;

ALMADRONES, L ;

HOSKINS, W .

JOURNAL OF CLINICAL ONCOLOGY, 1991, 9 (10) :1801-1805

[10] Phase III randomized trial of 12 versus 3 months of maintenance paclitaxel in patients with advanced ovarian cancer after complete response to platinum and paclitaxel-based chemotherapy: A Southwest Oncology Group and Gynecologic Oncology Group trial [J].

Markman, M ;

Liu, PY ;

Wilczynski, S ;

Monk, B ;

Copeland, LJ ;

Alvarez, RD ;

Jiang, C ;

Alberts, D .

JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (13) :2460-2465

← 1 2 →